Familial Adenomatous Polyposis Treatment Market Trends, Size, Competitive Analysis and Forecast 2021-2027
The global familial adenomatous polyposis treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Familial adenomatous polyposis (FAP) is an inherited disorder. It is characterized by the large intestine (colon) and rectum cancer. Additionally, the classic type of familial adenomatous polyposis in people begins to occur as early as in their teenage years causing them to develop multiple noncancerous in the colon. The major factor accelerating the growth of the market is the increasing prevalence of familial adenomatous polyposis across the globe.
According to the National Organization for Rare Disorders (NORD), FAP
affects males and females equally and occurs in approximately one in 5,000 to
10,000 individuals in the US. Additionally, it accounts for about 0.5% of all
cases of colorectal cancer. Furthermore, it is estimated that it affects almost
50,000 American families. Moreover, as per the American Society of Clinical
Oncology (ASCO), it is estimated that most people with FAP will have multiple
colon polyps by age 35 and approximately 30% of people with FAP do not have any
family history of the condition. Further, it is estimated that people affected
with FAP have a 100% risk of colorectal cancer if polyps are not removed.
Hence, the rising prevalence of the disease is driving the demand for familial
adenomatous polyposis treatment.
To Request a Sample of our Report on Familial
Adenomatous Polyposis Treatment Market:
https://www.omrglobal.com/request-sample/familial-adenomatous-polyposis-treatment-market
Some major players operating in
the market include Cancer Prevention Pharmaceuticals Inc, Marina Biotech, Inc,
and Thetis Pharmaceuticals LLC, among others. The market players are
contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in June 2020, Cancer Prevention
Pharmaceuticals, Inc. announced the submission of a New Drug Application (NDA)
to the US Food and Drug Administration (FDA). It was aimed to receive
accelerated approval for CPP-1X/sul for the treatment of adults with familial
adenomatous polyposis (FAP).
Market
Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Cancer Prevention Pharmaceuticals Inc,
Marina Biotech Inc, and Thetis Pharmaceuticals LLC, among others.
(Get 15% Discount on Buying this Report)
A
full Report of Familial Adenomatous Polyposis Treatment Market is Available @ https://www.omrglobal.com/industry-reports/familial-adenomatous-polyposis-treatment-market
Global Familial Adenomatous Polyposis Treatment Market
Report by Segment
By
Type
• Icosapent
• Eflornithine Hydrochloride
• Aspirin
• CEQ-508
• Others
By
Application
• Hospital
• Clinics
• Others
Global
Familial Adenomatous Polyposis Treatment Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment